CL2013002521A1 - Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios - Google Patents

Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios

Info

Publication number
CL2013002521A1
CL2013002521A1 CL2013002521A CL2013002521A CL2013002521A1 CL 2013002521 A1 CL2013002521 A1 CL 2013002521A1 CL 2013002521 A CL2013002521 A CL 2013002521A CL 2013002521 A CL2013002521 A CL 2013002521A CL 2013002521 A1 CL2013002521 A1 CL 2013002521A1
Authority
CL
Chile
Prior art keywords
cycloamino
carboxamide
intermediates
preparing
urea derivatives
Prior art date
Application number
CL2013002521A
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Erb
Isabelle Sylvie Gallaou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013002521(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2013002521A1 publication Critical patent/CL2013002521A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CL2013002521A 2011-03-03 2013-09-02 Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios CL2013002521A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (1)

Publication Number Publication Date
CL2013002521A1 true CL2013002521A1 (es) 2014-02-14

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013002521A CL2013002521A1 (es) 2011-03-03 2013-09-02 Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios

Country Status (33)

Country Link
US (3) US9650373B2 (enExample)
EP (1) EP2681192B1 (enExample)
JP (1) JP6022485B2 (enExample)
KR (1) KR101851421B1 (enExample)
CN (2) CN106083840B (enExample)
AR (2) AR088714A1 (enExample)
AU (1) AU2012222346B2 (enExample)
BR (1) BR112013021882A2 (enExample)
CA (1) CA2828509C (enExample)
CL (1) CL2013002521A1 (enExample)
CO (1) CO6751286A2 (enExample)
DK (1) DK2681192T3 (enExample)
EA (4) EA201892052A1 (enExample)
EC (1) ECSP13012914A (enExample)
ES (1) ES2663717T3 (enExample)
GT (1) GT201300211A (enExample)
HU (1) HUE036319T2 (enExample)
IL (1) IL228023A (enExample)
MA (1) MA34982B1 (enExample)
MX (2) MX351740B (enExample)
MY (1) MY163214A (enExample)
NO (1) NO2681192T3 (enExample)
PE (1) PE20140917A1 (enExample)
PH (1) PH12013501796A1 (enExample)
PL (1) PL2681192T3 (enExample)
PT (1) PT2681192T (enExample)
SG (1) SG192793A1 (enExample)
SI (1) SI2681192T1 (enExample)
TN (1) TN2013000354A1 (enExample)
TW (2) TWI607994B (enExample)
UA (1) UA112539C2 (enExample)
WO (1) WO2012117071A1 (enExample)
ZA (1) ZA201306174B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
SG11201702496XA (en) * 2014-11-14 2017-04-27 Gemphire Therapeutics Inc PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
JP2020516622A (ja) 2017-04-18 2020-06-11 ジェムフィアー セラピューティクス インコーポレイテッド ゲムカベン、薬学的に許容されるその塩、その組成物、およびその使用方法
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
ATE309241T1 (de) 1999-09-10 2005-11-15 Merck & Co Inc Tyrosin kinase inhibitoren
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
WO2007087427A2 (en) 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
US8940771B2 (en) 2007-12-20 2015-01-27 Novartis Ag Organic compounds
EP2235983B1 (en) * 2007-12-21 2011-07-20 Telefonaktiebolaget LM Ericsson (publ) Method, apparatus and computer program for handover from a first access point to a second access point
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
CN106083840B (zh) 2020-01-03
CN103402982B (zh) 2016-07-13
MY163214A (en) 2017-08-30
PE20140917A1 (es) 2014-08-14
PL2681192T3 (pl) 2018-06-29
KR20140009432A (ko) 2014-01-22
WO2012117071A1 (en) 2012-09-07
IL228023A0 (en) 2013-09-30
JP2014511387A (ja) 2014-05-15
IL228023A (en) 2017-04-30
TWI607994B (zh) 2017-12-11
US20170240509A1 (en) 2017-08-24
SI2681192T1 (en) 2018-04-30
US9776966B2 (en) 2017-10-03
CA2828509C (en) 2018-11-20
EA201792068A2 (ru) 2018-01-31
SG192793A1 (en) 2013-09-30
HUE036319T2 (hu) 2018-06-28
CA2828509A1 (en) 2012-09-07
TW201247660A (en) 2012-12-01
US9650373B2 (en) 2017-05-16
GT201300211A (es) 2014-12-30
EA032802B1 (ru) 2019-07-31
CN103402982A (zh) 2013-11-20
AU2012222346B2 (en) 2015-05-07
ES2663717T3 (es) 2018-04-16
MX347348B (es) 2017-04-17
TWI597279B (zh) 2017-09-01
ZA201306174B (en) 2014-05-28
EA201691331A1 (ru) 2017-01-30
CO6751286A2 (es) 2013-09-16
EA201792068A3 (ru) 2018-05-31
EP2681192B1 (en) 2017-12-27
DK2681192T3 (en) 2018-04-16
PT2681192T (pt) 2018-04-02
TW201722916A (zh) 2017-07-01
AR123584A2 (es) 2022-12-21
US20170355677A1 (en) 2017-12-14
MX2013010132A (es) 2013-10-30
EA201892052A1 (ru) 2019-02-28
EA025381B1 (ru) 2016-12-30
US20130331579A1 (en) 2013-12-12
TN2013000354A1 (en) 2015-01-20
KR101851421B1 (ko) 2018-04-23
NZ614173A (en) 2015-04-24
EA201391267A1 (ru) 2014-01-30
AR088714A1 (es) 2014-07-02
NO2681192T3 (enExample) 2018-05-26
US10059670B2 (en) 2018-08-28
MX351740B (es) 2017-10-26
PH12013501796A1 (en) 2022-10-26
BR112013021882A2 (pt) 2016-07-19
CN106083840A (zh) 2016-11-09
MA34982B1 (fr) 2014-03-01
AU2012222346A1 (en) 2013-08-29
ECSP13012914A (es) 2013-11-29
EP2681192A1 (en) 2014-01-08
UA112539C2 (uk) 2016-09-26
JP6022485B2 (ja) 2016-11-09

Similar Documents

Publication Publication Date Title
EP2753700A4 (en) fermentation
SI2549870T1 (sl) Postopek za pripravo karbamoilpiridonskih derivatov in intermediatov
CO6890099A2 (es) Nuevos derivados dihidroquinolina-2-ona
HUE052485T2 (hu) RNA készítmény immunterápiára
EP2684880A4 (en) DISPIROPYRROLIDINDERIVAT
BR112014009302A2 (pt) processo para preparar derivativos de quinolina
HUE038773T2 (hu) Új biciklusos dihidrokinolin-2-on származékok
BR112013023064A2 (pt) processo de síntese de derivados de cetobenzofurano
CO7061068A2 (es) Derivados de polimixina
BR112014009795A2 (pt) método
BR112014007958A2 (pt) método
BR112014001851A2 (pt) método
BR112014001237A2 (pt) método
IL227413A0 (en) Coating and its manufacturing process
EP2665431C0 (en) Drug delivery technology
CL2013002521A1 (es) Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios
HRP20181747T1 (hr) Postupak za selektivnu proizvodnju n-metil-para-anisidina
CO6960557A2 (es) Derivados de 2-yodo-imidazol
EP2794841A4 (en) BIOREACTOR
EP2797752A4 (en) CUTTING MEDIA
IL232424A (en) Process for the preparation of 1-noble-4-phenylsulfonylprolinamide and intermediates
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
DK2476534T3 (da) Fremgangsmåde til formning
CO6852074A2 (es) Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida
PT2665720E (pt) Derivados de 2-metoxi-piridin-4-ilo